Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Chiron's Menjugate approved in Ireland

Aug. 10, 2000

New peptides under development at Ludwig Institute

Aug. 9, 2000

New IL-5 inhibitors under development at Janssen

Aug. 8, 2000

New TNF inhibitors under development at Daiichi

Aug. 7, 2000

Peptide Therapeutics awarded SBIR grant for West Nile vaccine

Aug. 4, 2000

New human lymphocytic membrane proteins under study at Incyte

Aug. 3, 2000

Improved recombinant HBsAg for use in vaccines under study at Merck

Aug. 2, 2000

Rapamune regulatory application receives negative opinion from CPMP

Aug. 1, 2000

Cimetidine as treatment for viral warts in children and adults

Aug. 1, 2000

Novel classes of calcium-activated SK/IK/BK channel modulators designed at NeuroSearch

July 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...